The distinctive black-and-white sweater-striped pill was supposed to make millions of Americans thin--and its manufacturer rich. But a year after the drug called Redux was approved by the Food and Drug Administration for sale in the U.S., the hot new diet pill has fallen short on both counts. At $200 million a year, sales are flat and lagging far behind the initial $1 billion-a-year expectations. Some who have taken Redux have discovered that it is not the magic melting potion they hoped it would be; others who were thinking of taking it have been frightened off by stories about potentially harmful...
To continue reading:
or
Log-In
